Generation and fate of regioisomeric side-chain impurities in the preparation of fosinopril sodium

被引:21
作者
Anderson, NG
Coradetti, ML
Cronin, JA
Davies, ML
Gardineer, MB
Kotnis, AS
Lust, DA
Palaniswamy, VA
机构
[1] Bristol Myers Squibb Co, Chem Proc Dev, New Brunswick, NJ 08903 USA
[2] Bristol Myers Squibb Co, Analyt Res & Dev, New Brunswick, NJ 08903 USA
[3] Bristol Myers Squibb, Pharmaceut, Qual Control, Dublin, Ireland
关键词
D O I
10.1021/op9702105
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
A regioisomeric impurity is routinely formed during preparation of the first intermediate of the fosinopril sodium side chain, This first step, the radical-initiated condensation of 4-phenyl-1-butene (1) and aqueous hypophosphorous acid, provides low levels of the phosphinic acid (8) resulting from carbon-phosphorus bond formation to the internal olefin carbon, This impurity was isolated by preparative chromatography, and its structure was proven by independent synthesis, Subsequent reactions of 8 in the two following steps produce the corresponding regioisomeric impurities, Pure samples of these impurities were prepared for HPLC analysis to determine potential impact on the quality of intermediates downstream, The initial regioisomer averages 2 area % in manufacturing batches, and the levels of regioisomeric impurities diminish sharply with sequential conversion to further side-chain intermediates, After two steps, the levels of the regioisomeric impurities have been less than 0.08 area % in production batches; therefore, no significant amount of side-chain regioisomeric impurities (i.e., <0.1%) is expected to be found in production batches of fosinopril sodium side chain.
引用
收藏
页码:315 / 319
页数:5
相关论文
共 13 条
[1]   ON THE ROLE OF LEUCINE IN TERPENOID METABOLISM [J].
ANASTASIS, P ;
FREER, I ;
OVERTON, KH ;
PICKEN, D ;
RYCROFT, DS ;
SINGH, SB .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1987, (11) :2427-2436
[2]   Process development for the preparation of a monopril intermediate by a trimethylsilyl-modified Arbuzov reaction [J].
Anderson, NG ;
Ciaramella, BM ;
Feldman, AF ;
Lust, DA ;
Moniot, JL ;
Moran, L ;
Polomski, RE ;
Wang, SSY .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 1997, 1 (03) :211-216
[3]   Sulfonation with inversion by Mitsunobu reaction: An improvement on the original conditions [J].
Anderson, NG ;
Lust, DA ;
Colapret, KA ;
Simpson, JH ;
Malley, MF ;
Gougoutas, JZ .
JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (22) :7955-7958
[4]   PALLADIUM-CATALYZED, REGIOSELECTIVE REDUCTION OF 1,2-EPOXIDES BY AMMONIUM FORMATE [J].
DRAGOVICH, PS ;
PRINS, TJ ;
ZHOU, R .
JOURNAL OF ORGANIC CHEMISTRY, 1995, 60 (15) :4922-4924
[5]  
ENGEL R, 1988, SYNTHESIS CARBON PHO, P169
[6]  
ER SQUIBB & SONS INC, 1983, Patent No. [US 4371526, 4371526]
[7]  
KARANEWSKY DS, 1984, Patent No. 4493972
[8]  
KARANEWSKY DS, 1984, Patent No. 4432971
[9]   ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS - MERCAPTAN, CARBOXYALKYL DIPEPTIDE, AND PHOSPHINIC ACID INHIBITORS INCORPORATING 4-SUBSTITUTED PROLINES [J].
KRAPCHO, J ;
TURK, C ;
CUSHMAN, DW ;
POWELL, JR ;
DEFORREST, JM ;
SPITZMILLER, ER ;
KARANEWSKY, DS ;
DUGGAN, M ;
ROVNYAK, G ;
SCHWARTZ, J ;
NATARAJAN, S ;
GODFREY, JD ;
RYONO, DE ;
NEUBECK, R ;
ATWAL, KS ;
PETRILLO, EW .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (06) :1148-1160
[10]   STEREOSPECIFIC FRIEDEL-CRAFTS ALKYLATION OF BENZENE WITH 4-MESYLOXY-L-PROLINES - A NEW SYNTHESIS OF 4-PHENYLPROLINES [J].
KRONENTHAL, DR ;
MUELLER, RH ;
KUESTER, PL ;
KISSICK, TP ;
JOHNSON, EJ .
TETRAHEDRON LETTERS, 1990, 31 (09) :1241-1244